SG48841A1 - 06-methylguanine-DNA-methyltransferase (MGMT) specific antibodies - Google Patents

06-methylguanine-DNA-methyltransferase (MGMT) specific antibodies

Info

Publication number
SG48841A1
SG48841A1 SG1996002679A SG1996002679A SG48841A1 SG 48841 A1 SG48841 A1 SG 48841A1 SG 1996002679 A SG1996002679 A SG 1996002679A SG 1996002679 A SG1996002679 A SG 1996002679A SG 48841 A1 SG48841 A1 SG 48841A1
Authority
SG
Singapore
Prior art keywords
pct
hybridoma ecacc
nov
mgmt
date jun
Prior art date
Application number
SG1996002679A
Other languages
English (en)
Inventor
Teck Choon Ayi
Benjamin Fuk Loi Li
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Publication of SG48841A1 publication Critical patent/SG48841A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG1996002679A 1992-11-27 1993-11-23 06-methylguanine-DNA-methyltransferase (MGMT) specific antibodies SG48841A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224888A GB9224888D0 (en) 1992-11-27 1992-11-27 Monoclonal antibody

Publications (1)

Publication Number Publication Date
SG48841A1 true SG48841A1 (en) 1998-05-18

Family

ID=10725777

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002679A SG48841A1 (en) 1992-11-27 1993-11-23 06-methylguanine-DNA-methyltransferase (MGMT) specific antibodies

Country Status (10)

Country Link
US (1) US5817514A (de)
EP (1) EP0670908B1 (de)
AT (1) ATE169680T1 (de)
AU (1) AU688289B2 (de)
CA (1) CA2149867A1 (de)
DE (1) DE69320364T2 (de)
ES (1) ES2119992T3 (de)
GB (1) GB9224888D0 (de)
SG (1) SG48841A1 (de)
WO (1) WO1994012660A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase
WO2002027019A1 (en) * 2000-09-29 2002-04-04 The Johns Hopkins University School Of Medicine Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
ATE419378T1 (de) * 2001-04-10 2009-01-15 Ecole Polytech Verfahren zur verwendung von o6-alkylguanin-dns alkyltransferasen
AU2007207465B2 (en) 2006-01-18 2012-12-06 Merck Patent Gmbh Specific therapy using integrin ligands for treating cancer
CN101588812A (zh) 2007-01-18 2009-11-25 默克专利有限公司 使用整联蛋白配体治疗癌的特异疗法和药物
EP2409700A1 (de) 2007-05-08 2012-01-25 Schering Corporation Verfahren zur Behandlung mit intravenösen Formulierungen mit Temozolomid
WO2009154461A1 (en) * 2008-06-19 2009-12-23 Prothix Bv Use of anti-factors xi antibodies for prevention of thrombus formation
NZ597339A (en) 2009-05-25 2013-10-25 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
US9220771B2 (en) 2010-07-16 2015-12-29 Merck Patent Gmbh Peptide for use in the treatment of breast cancer and/or bone metastases
KR20140107195A (ko) * 2011-11-25 2014-09-04 프라운호퍼-게젤샤프트 추르 푀르데룽 데어 안제반텐 포르슝 에 파우 Ｓｎａｐ／ｃｌｉｐ 태그의 검출용 단일클론 항체
MX349562B (es) 2011-12-09 2017-08-02 Pasteur Institut Ensayo de inmuno deteccion multiplex.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase

Also Published As

Publication number Publication date
AU688289B2 (en) 1998-03-12
AU5570594A (en) 1994-06-22
ATE169680T1 (de) 1998-08-15
CA2149867A1 (en) 1994-06-09
DE69320364T2 (de) 1998-12-10
EP0670908B1 (de) 1998-08-12
ES2119992T3 (es) 1998-10-16
GB9224888D0 (en) 1993-01-13
EP0670908A1 (de) 1995-09-13
DE69320364D1 (de) 1998-09-17
US5817514A (en) 1998-10-06
WO1994012660A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
AU2001258567A1 (en) Humanised antibodies to the epidermal growth factor receptor
SG48841A1 (en) 06-methylguanine-DNA-methyltransferase (MGMT) specific antibodies
NZ508381A (en) Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5)
ATE212038T1 (de) Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung
CA2124126A1 (en) Monoclonal antibodies and fv specific for cd2 antigen
ATE208820T1 (de) Humanisierte antikoerper
CA2212150A1 (en) Monoclonal antibodies for human osteogenic cell surface antigens
PL317536A1 (en) Monoclonal antibody against cd 44v6
EP1860188A3 (de) Menschliches Rezeptor für Zytokine
Thomas et al. Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous‐cell carcinoma
AU4326693A (en) Monoclonal antibodies to glycoprotein p
GR3029483T3 (en) Antibodies against t-cells as therapeutics
DE59812529D1 (de) Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
ATE40216T1 (de) Monoklonaler antikoerper.
GB2284608A (en) 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies
DE69533504D1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
IL122011A0 (en) Human beta 2 integrin alpha subunit
Leanderson et al. Effects of μ‐specific antibodies on B cell growth and maturation
ATE251643T1 (de) Antikörper 67d2 gegen cd164
Kurita et al. Isotype Specific Immunoregulation: Role of FcαR+ T Cells and IBFα in IgA Responses
Seo et al. Utilization of leucine methyl ester for the generation of hybridomas producing monoclonal antibodies specific to tumor-associated antigens
Rouger et al. Challenge of Human Monoclonal Antibodies.
AU6162794A (en) Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor